Clinical Trials Directory

Trials / Completed

CompletedNCT01921582

A Comparison of Methylphenidate and Cognitive Behavioural Therapy for the Treatment of Binge Eating Disorder

A Randomized Comparison of Osmotic Release Oral System Methylphenidate and Cognitive Behavioural Therapy for the Treatment of Obese Patients With Binge Eating Disorder

Status
Completed
Phase
Phase 2
Study type
Interventional
Enrollment
51 (actual)
Sponsor
Centre for Addiction and Mental Health · Academic / Other
Sex
Female
Age
18 Years – 50 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is to determine whether methylphenidate is effective in the treatment of binge eating disorder, in a randomized controlled trial extended release methylphenidate versus cognitive behavioral therapy for binge eating disorder in overweight or obese adult females.

Detailed description

Fifty-six adult female outpatients with binge eating disorder will receive 12 weeks of methylphenidate (dosage 18-72 mg) or 12 sessions of manualized cognitive behavioral therapy. Participants will complete interviewer-rated and self-report measures of eating, mood, attention, and personality features before treatment, after 6 weeks of treatment, immediately after treatment is completed, and 3 months after treatment is completed.

Conditions

Interventions

TypeNameDescription
DRUGMethylphenidate* Weekly appointments with study psychiatrists for the first four weeks, and then biweekly appointments for the last eight weeks. * Intervention will consist of medication as well as components of "Med-Plus" treatment (e.g., medication management, general support, and compliance enhancement strategies).
BEHAVIORALCognitive Behavioral TherapyCognitive Behavior Therapy will include three phases: * Phase 1 undertakes to eliminate binge episodes and introduce a 'regular' pattern of eating; * Phase 2 aims to reduce food intake and restructure eating-related cognitions; * Phase 3 focuses upon relapse prevention

Timeline

Start date
2013-08-01
Primary completion
2015-09-01
Completion
2015-09-01
First posted
2013-08-13
Last updated
2017-02-06

Locations

1 site across 1 country: Canada

Source: ClinicalTrials.gov record NCT01921582. Inclusion in this directory is not an endorsement.